<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhong H</submitter><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><pagination>5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8941742</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Overactive bladder (OAB) affects 12 to 30% of the world's population. The accompanying urinary urgency, frequency and incontinence can have a profound effect on quality of life, leading to depression, social isolation, avoidance of sexual activity and loss of productivity. Conservative measures such as lifestyle modification and pelvic floor physical therapy are the first line of treatment for overactive bladder. Patients who fail these may go on to take medications, undergo neuromodulation or receive injection of botulinum toxin into the bladder wall. While effective, medications have side effects and suffer from poor adherence. Neuromodulation and botulinum toxin injection are also effective but are invasive and not acceptable to some patients.&lt;h4>Methods&lt;/h4>We have d</pubmed_abstract><journal>Bioelectronic medicine</journal><pubmed_title>Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder.</pubmed_title><pmcid>PMC8941742</pmcid><funding_grant_id>R44 DK129164</funding_grant_id><funding_grant_id>R44DK129164</funding_grant_id><pubmed_authors>Edgerton VR</pubmed_authors><pubmed_authors>Kreydin E</pubmed_authors><pubmed_authors>Kohli P</pubmed_authors><pubmed_authors>Zhong H</pubmed_authors><pubmed_authors>Perez L</pubmed_authors><pubmed_authors>Gad P</pubmed_authors><pubmed_authors>Liu E</pubmed_authors><pubmed_authors>Ginsberg D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder.</name><description>&lt;h4>Background&lt;/h4>Overactive bladder (OAB) affects 12 to 30% of the world's population. The accompanying urinary urgency, frequency and incontinence can have a profound effect on quality of life, leading to depression, social isolation, avoidance of sexual activity and loss of productivity. Conservative measures such as lifestyle modification and pelvic floor physical therapy are the first line of treatment for overactive bladder. Patients who fail these may go on to take medications, undergo neuromodulation or receive injection of botulinum toxin into the bladder wall. While effective, medications have side effects and suffer from poor adherence. Neuromodulation and botulinum toxin injection are also effective but are invasive and not acceptable to some patients.&lt;h4>Methods&lt;/h4>We have d</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T22:12:41.508Z</modification><creation>2025-04-04T22:12:41.508Z</creation></dates><accession>S-EPMC8941742</accession><cross_references><pubmed>35317851</pubmed><doi>10.1186/s42234-022-00087-x</doi></cross_references></HashMap>